(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.16%) $82.50
(1.77%) $2.07
(-0.65%) $2 342.30
(-1.30%) $27.30
(-0.29%) $958.70
(0.18%) $0.934
(0.28%) $11.01
(0.11%) $0.797
(0.01%) $93.31
4.17% ¥ 2 719.50
Live Chart Being Loaded With Signals
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company...
Stats | |
---|---|
Dzisiejszy wolumen | 1.28M |
Średni wolumen | 3.84M |
Kapitalizacja rynkowa | 4 028.63B |
EPS | ¥0 ( 2024-02-07 ) |
Następna data zysków | ( ¥17.50 ) 2024-05-13 |
Last Dividend | ¥21.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 40.85 |
ATR14 | ¥1.972 (0.07%) |
Wolumen Korelacja
Terumo Corporation Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Terumo Corporation Korelacja - Waluta/Towar
Terumo Corporation Finanse
Annual | 2022 |
Przychody: | ¥820.21B |
Zysk brutto: | ¥417.37B (50.89 %) |
EPS: | ¥59.50 |
FY | 2022 |
Przychody: | ¥820.21B |
Zysk brutto: | ¥417.37B (50.89 %) |
EPS: | ¥59.50 |
FY | 2022 |
Przychody: | ¥703.30B |
Zysk brutto: | ¥369.34B (52.52 %) |
EPS: | ¥117.45 |
FY | 2021 |
Przychody: | ¥613.84B |
Zysk brutto: | ¥326.62B (53.21 %) |
EPS: | ¥102.33 |
Financial Reports:
No articles found.
Terumo Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥19.00 (N/A) |
¥0 (N/A) |
¥21.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥1.063 | 2000-03-28 |
Last Dividend | ¥21.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 48 | -- |
Total Paid Out | ¥341.63 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.34 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.45 | |
Div. Directional Score | 9.53 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8031.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7278.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6516.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5757.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4540.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3762.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3030.T | Ex Dividend Junior | 2024-02-28 | Sporadic | 0 | 0.00% | |
1909.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9882.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8925.T | No Dividend Player | 2023-07-28 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.112 | 1.500 | 7.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0585 | 1.200 | 8.05 | 9.66 | [0 - 0.3] |
returnOnEquityTTM | 0.0827 | 1.500 | -0.192 | -0.288 | [0.1 - 1] |
payoutRatioTTM | 0.323 | -1.000 | 6.77 | -6.77 | [0 - 1] |
currentRatioTTM | 1.905 | 0.800 | 5.48 | 4.38 | [1 - 3] |
quickRatioTTM | 1.034 | 0.800 | 8.62 | 6.90 | [0.8 - 2.5] |
cashRatioTTM | 0.466 | 1.500 | 8.52 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.134 | -1.500 | 7.77 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 45.48 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 89.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 40.66 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.186 | -1.500 | 9.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.513 | 1.000 | 4.79 | 4.79 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.146 | 1.000 | 9.08 | 9.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.592 | 1.000 | 7.82 | 7.82 | [0.2 - 2] |
assetTurnoverTTM | 0.523 | 0.800 | 9.84 | 7.88 | [0.5 - 2] |
Total Score | 12.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 39.22 | 1.000 | 6.14 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0827 | 2.50 | -0.124 | -0.288 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 40.66 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.264 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 89.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.323 | 1.500 | 6.77 | -6.77 | [0 - 1] |
pegRatioTTM | 2.65 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.151 | 1.000 | 8.72 | 0 | [0.1 - 0.5] |
Total Score | 6.45 |
Terumo Corporation
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej